脑部放疗，上午比下午敏感许多！
7 I" o% u9 r' R8 H6 ?4 y8 }: ~: [
8 {0 x# z: p4 r+ Z, i3 H: }& j# x1 k0 D9 g
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
$ ~2 x5 a; S$ t8 U, ?- bGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?: y% g# A: ]9 G( y
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T. p. ], F1 O3 @* |8 X8 k
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.1 G; j; R6 o$ M; W5 v
, g) K9 X" A0 _; W$ H4 N U: z e+ k3 DAbstract
$ {! S' L: s8 }( h) q( ]BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time./ c+ G ?- |2 l; Z, H
' Y6 h! [4 A8 n5 J9 r: S; vMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
/ U6 E/ g& p1 o; a4 I2 c% G* `! T2 N/ R5 v7 g/ J8 t
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
3 S1 P. M9 y* j2 N H
2 g. Z ^) Z0 `, I [) KCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
2 g( h2 X4 Y$ R5 n- g/ U
2 e( w: P a4 ~0 y. C- e# M' K |
- e. P7 K( R/ y- O: R& v7 S' @$ f
显身卡
